Dhampur Bio Organics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
DBOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dhampur Bio Organics reported audited standalone FY26 results with revenue from operations of Rs. 3,106.17 crore, up 14.4% from Rs. 2,714.40 crore in FY25. Profit after tax more than doubled to Rs. 24.97 crore from Rs. 12.09 crore in the prior year, representing 107% PAT growth. The board recommended a dividend of Rs. 1.50 per share (15%) for FY26, payable to shareholders on record date July 17, 2026. Key corporate actions include acquisition of Sonitron Chemicals Private Limited, re-designation of Mr. Gautam Goel as Chairman & CEO, and re-appointment of Mittal Gupta & Co. as statutory auditors for another 5-year term. The Income Tax Department conducted a search operation in October-November 2025; the company states no adjustments were required in the financial results. Subsequent to year-end, the company entered an agreement to sell its Meerganj sugar unit for Rs. 305 crore. The audit report carried an unmodified (clean) opinion.
The strong PAT growth of over 100% year-on-year is positive for shareholders, and the dividend payment adds to investor returns. However, investors should monitor the pending IT search outcome and the impact of the planned sale of the Meerganj unit on future revenue streams. The related party remuneration revisions for family members of the MD may attract shareholder scrutiny at the AGM.